2 terminated, 1 completed. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 2, Completed 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Healios K.K.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) MultiStem, Placebo - ARDS | Phase 2 / Phase 3 | Terminated | Healios K.K. | 22 | 2020-04-28 | 2026-10-16 |
| MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study MultiStem, Placebo - Ischemic Stroke | Phase 3 | Terminated | Healios K.K. | 206 | 2018-07-28 | 2026-08-11 |
| Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements HLCM051, Placebo - Stroke, Acute | Phase 2 / Phase 3 | Completed | Healios K.K. | 206 | 2017-11-15 | 2024-01-17 |
COVID-19 (1) · Dyspnea (1) · Ischemic Stroke (1) · Stroke (1)
United States (2) · Japan (1) · Taiwan (1)
Eric Jenkins, MD (1) · Robert W Mays, PhD (1)